Probing the peripheral anionic site of acetylcholinesterase with quantitative structure activity relationships for inhibition by biphenyl-4-acyoxylate-4′-N-butylcarbamates

Journal of Biochemical and Molecular Toxicology

Volumn 19, Issue 4, 2005, Pages 234-243

  Lin, Gialih ^a   Chen, Gan Hong ^a   Yeh, Shih Chieh ^a   Lu, Chun Ping ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Acetylcholinesterase; Carbamate Inhibitors; Peripheral Anionic Site; QSAR

Indexed keywords

4,4' BIPHENYL DERIVATIVE; ACETYLCHOLINESTERASE; BIPHENYL 4 ACYOXYLATE 4' N BUTYLCARBAMATE DERIVATIVE; BIPHENYL DERIVATIVE; CARBAMIC ACID DERIVATIVE; N BUTYLCARBAMATE DERIVATIVE; PHENOL DERIVATIVE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CALCULATION; CATALYST; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STRUCTURE; ENZYME SUBSTRATE; HYDROPHOBICITY; MOLECULAR INTERACTION; MOLECULAR PROBE; PARAMETER; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION ANALYSIS; STEREOCHEMISTRY; STEREOSPECIFICITY; STRUCTURE ANALYSIS; SYNTHESIS;

ACETYLCHOLINESTERASE; BINDING SITES; CARBAMATES; CHOLINESTERASE INHIBITORS; HUMANS; KINETICS; MODELS, CHEMICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 24944461918     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20087     Document Type: Article

References (43)

1. Taylor P. Development of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease. Neurology 1998;51(1, Suppl 1):S30-S35, S65-S67.
2. Rosenberry TL. Acetylcholinesterase. Adv Enzymol Relat Areas Mol Biol 1975;43:103-218.
3. Quinn DM. Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 1987;87:955-979.
4. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science 1991;53:872-879.
5. Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth L, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 1993;90:9031-9035.
6. Harel M, Quinn DM, Nair HK, Silman I, Sussman JL. The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. J Am Chem Soc 1996;118:2340-2346.
7. Bartolucci C, Perola E, Cellai L, Brufani M, Lamba D. "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Biochemistry 1999;38:5714-5719.
8. Radić Z, Pickering N, Vellom DC, Camp S, Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 1993;32:12074-12084.
9. Taylor P, Mayer RH, Himel CM. Conformers of acetylcholinesterase: A mechanism of allosteric control. Mol Pharmacol 1994;45:74-83.
10. Pang Y-P, Quiram P, Jalacie T, Hong F, Brimijoin S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem 1996;271:23646-23649.
11. Giacobini E. Cholinestease inhibitors do more than inhibit cholinesterase. In: Becker R, Giacobini E, editors. Alzheimer's disease: Molecular biology to therapy. Boston, MA: Birkhauser; 1997. pp 188-204.
12. Soreq H, Zakut H. Human cholinesterases and anticholinesterases. New York: Academic; 1983.
13. Taylor P. In: Gilman AG, Nies AS, Rail TW, Taylor P, editors. The pharmacological basis of therapeutics, 5th edition. New York: Macmillan; 1975. pp 131-150.
14. Bar-On P, Millard CB, Harel M, Dvir H, Enz A, Sussman JL, Silman I. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry 2002;41:3555-3564.
15. Lin G, Lai C-Y, Liao W-C. Molecular recognition by acetylcholinesterase at the peripheral anionic site: Structure-activity relationships for inhibitions by aryl carbamates. Bioorg Med Chem 1999;7:2683-2689.
16. Aldridge WN, Reiner E. In: Neuberger A, Tatun EL, editors. Enzyme inhibitors as substrates. Amsterdam: North-Holland; 1972, pp. 123-145.
17. Hart GJ, O'Brien RD. Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate. Biochemistry 1973;12:2940-2945.
18. Hosie L, Sutton LD, Quinn DM. p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase. J Biol Chem 1987;262:260-264.
19. Lin G, Lai C-Y, Liao W-C, Kuo B-H, Lu C-P. Structure-reactivity relationships as probes for the inhibition mechanism of cholesterol esterase by aryl carbamates, I: Steady-state kinetics. J Chin Chem Soc 2000;47:489-500.
20. Abeles RH, Maycock AL. Suicide enzyme inactivators. Acc Chem Res 1976;9:313-319.
21. Lin G, Lai C-Y, Liao W-C, Liao B-H, Lu C-P. Structure-reactivity relationships as probes for the inhibition mechanism of acetylcholinesterase by aryl carbamates, I: Steady-state kinetics. J Chin Chem Soc 2003;50:1259-1265.
22. Lin G, Liao W-C, Chiou S-Y. Quantitative structure-activity relationships for the pre-steady-state inhibition of cholesterol esterase by 4-nitrophenyl-N-substituted carbamates. Bioorg Med Chem 2000;8:2601-2607.
23. March J. Advanced organic chemistry, 4th edition. New York: Wiley; 1992.
24. Isaacs N. Physical organic chemistry, 2nd edition. Harlow, Essex: Longman; 1995.
25. Lowry TH, Richardson KS. Mechanism and theory in organic chemistry, 3rd edition. New York: Harper & Row; 1992.
26. Lin G, Lai C-Y. Hammett analysis of the inhibition of pancreatic cholesterol esterase by substituted phenyl-N-butylcarbamate. Tetrahedron Lett 1995;36:6117-6120.
27. Feaster SR, Lee K, Baker N, Hui DY, Quinn DM. Molecular recognition by cholesterol esterase of active site ligands: Structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamyl enzyme turnover. Biochemistry 1996;35:16723-16734.
28. Lin G. Hammett-Taft cross-interaction correlations for the inhibition mechanism of cholesterol esterase by substituted phenyl N-substituted carbamates. J Phys Org Chem 2000;13:313-321.
29. LinG, Lai C-Y. Linear free energy relationships of the inhibition of pancreatic cholesterol esterase by 4-nitrophenyl-N-alkylcarbamate. Tetrahedron Lett 1996;2:193-196.
30. Järv J, Kesvatera T, Aavikasar A. Structure-activity relationships in acetylcholinesterase reactions. Hydrolysis of non-ionic acetic esters. Eur J Biochem 1976;67:315-322.
31. Masson P, Xie W, Foroment M-T, Levitsky V, Fortier P-L, Albaret C, Lockridge O. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Biochim Biophys Acta 1999;1433:281-293.
32. Ellman CL, Courtney KD, Andres VJ, Featherstone RM. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
33. Lin G, Tsai Y-C, Liu H-C, Liao W-C, Chang C-H. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase. Biochem Biophys Acta 1998;1388:161-174.
34. Lin G, Shieh C-T, Tsai Y-C, Hwang C-I, Lu C-P, Chen G-H. Structure-reactivity probes for active site shapes of cholesterol esterase by carbamate inhibitors. Biochem Biophys Acta 1999;35905:161-174.
35. Lin G, Shieh C-T, Ho H-C, Chouhwang J-Y, Lin W-Y, Lu C-P. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Biochemistry 1999;38:9971-9981.
36. Lin G, Chouhwang J-Y. Quantitative structure-activity relationship for the inhibition of Pseudomonas species lipase by 4-nitrophenyl-N-substituted carbamate, I: The steady-state kinetics. J Biochem Mol Biol Biophys 2001;5:301-308.
37. Lin G, Tsai H-J, Tsai, T-H. Cage amines as the stopper inhibitors of cholinesterase. Bioorg Med Chem Lett 2003; 13:2887-2890.
38. Lin G. Structure-reactivity relationships as probes for the inhibition mechanism of cholesterol esterase by aryl carbamates, I: Hammett-Taft cross-interaction correlations. J Chin Chem Soc 2004;51:423-429.
39. Lin G, Liu Y-C, Lin Y-F, Wu Y-G. Ortho effects in quantitative structure activity relationships for acetylcholinesterase inhibition by aryl carbamates. J Enzym Inhib Med Chem 2004;19:395-401.
40. Lin G, Liao W-C, Chan C-H, Wu Y-H, Tsai H-J, Hsieh C-W. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates. J Biochem Mol Toxicol 2004;18:353-360.
41. Lin G, Tseng H-C, Chio A-C, Tseng T-M, Tsai B-Y. A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butyl-carbamates. Bioorg Med Chem Lett 2005;15:951-955.
42. Gavuzzo E, Pomponi M. Inhibition of acetylcholinesterase by physostigmine analogs: Conformational mobility of cysteine loop due to the steric effect of the alkyl chain. J Biochem Mol Toxicol 2002;16:64-69.
43. Savini L, Gaeta A, Fattorusso C, Catalanotti B, Campiani G, Chiasserini L, Pellerano C, Novellino E, McKissic D, Saxena A. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. J Med Chem 2003;46:1-4.